Search…

    Saved articles

    You have not yet added any article to your bookmarks!

    Browse articles
    Select News Languages

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    HSE to Discuss Skyclarys Drug Decision

    3 weeks ago

    15

    0

    The HSE Senior Leadership Team is set to meet regarding the drug Skyclarys, intended for Friedreich's ataxia patients. Earlier recommendations advised against public funding due to cost concerns. Approximately 200 individuals in Ireland are affected by this condition. Biogen, the drug's manufacturer, is in negotiations with the HSE over pricing, which is currently deemed unaffordable.
    Click here to Read more
    Prev Article
    Never Fully Dressed Launches Beauty Line
    Next Article
    Over 200 Offaly Children Await Early Years Places

    Related Health Updates:

    Comments (0)

      Leave a Comment